Senate opens inquiry into EpiPen pricing

The Senate has opened an investigation into EpiPen pricing.
(Image credit: Getty Images)

The Senate Permanent Subcommittee on Investigations is opening an inquiry into the pharmaceutical company Mylan's pricing of the EpiPen, it announced on Wednesday. The EpiPen, which stops potentially fatal allergic reactions by injecting a precise dose of epinephrine, now costs about $600 for a two-pack, up from roughly $100 when Mylan acquired EpiPen in 2007.

Mylan last month announced it would offer a generic version of the EpiPen in response to backlash over the skyrocketing prices, but lawmakers are still dissatisfied. The inquiry will be headed by Sen. Rob Portman (R-Ohio) and Sen. Claire McCaskill (D-Mo.), but Congress has only a few weeks to act before it adjourns Oct. 1 for an election season recess.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Jeva Lange

Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.